Increased aneuploidy in spermatozoa from testicular tumour patients after chemotherapy with cisplatin, etoposide and bleomycin

Human Reproduction

Volumn 16, Issue 6, 2001, Pages 1204-1208

  De Mas, Philippe ^b   Daudin, Myriam ^a   Vincent, Marie Claire ^b   Bourrouillou, Georges ^a,b   Calvas, Patrick ^b   Mieusset, Roger ^a   Bujan, Louis ^a  

^a Serv Univ Psychiat l'Enfant l'A   (France)

^b CHU PURPAN   (France)

Author keywords

Chemotherapy; FISH; PEB side effects; Sperm aneuploidy; Testicular cancer

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ADULT; ANEUPLOIDY; ARTICLE; AZOOSPERMIA; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CHROMOSOME 16; CHROMOSOME 18; CHROMOSOME 7; CLINICAL ARTICLE; CONTRACEPTION; CONTROLLED STUDY; DISOMY; DNA PROBE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC COUNSELING; HEALTH PRACTITIONER; HIGH RISK PATIENT; HUMAN; MALE; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; PATIENT COUNSELING; PREGNANCY; SEMINOMA; SPERMATOGENESIS; SPERMATOZOON; TESTIS CANCER; TREATMENT OUTCOME; X CHROMOSOME; Y CHROMOSOME;

EID: 0034974659     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/16.6.1204     Document Type: Article

References (39)

1. Testicular cancer in nine Northern European countries
2. Absence of chromosomal instability in spermatozoa of men affected by testicular cancer
3. Chromosomal damage in sperm of patients surviving Hodgkin's disease following MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) therapy with and without radiotherapy
4. The induction of chromosome aberrations by cis-platinum (II) diaminodichloride in Drosophila melanogaster
5. Evaluation of primary standard cisplatin-based chemotherapy for clinical stage II nonseminomatous germ cell tumours of the testis
6. Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: A medical research council report
7. Inhibitors of DNA topoisomerase II prevent chromatid separation in mammalian cells but do not prevent exit from mitosis
8. Estimation of aneuploidy for chromosomes 3, 7, 16, X, and Y in spermatozoa from 10 normospermic men using fluorescence in situ hybridization
9. Use of multicolour chromosome painting to identify chromosomal rearrangements in human lymphocytes exposed to bleomycin: A comparison with conventional cytogenetic analysis of Giemsa-stained chromosomes
10. Chromosome studies in human sperm nuclei using fluorescence in-situ hybridization (FISH)
11. Testicular cancer
12. Sperm chromosome studies in individuals treated for testicular cancer
13. Human sperm chromosomes long-term effect of cancer treatment
14. Human aneuploidy: Incidence, origin and etiology
15. The effects of cisplatin on murine metaphase II oocytes
16. DNA topoisomerase II must act at mitosis to prevent nondisjunction and chromosome breakage
17. Chromosome analysis of human sperm. I. First result with a modified method
18. Chromosome aberrations in 450 sperm complements from eight controls and lack of increase after chemotherapy in two patients
19. Botran and bleomycin induce crossing-over, and bleomycin also increases aneuploidy in diploid strains of Aspergillus
20. Fragmentation of centromeric DNA and prevention of homologous chromosome separation in male mouse meiosis in vivo by the topoisomerase II inhibitor etoposide
21. Preferential pericentric lesions and aneuploidy induced in mouse oocytes by the topoisomerase II inhibitor etoposide
22. Absence of selection against aneuploid mouse sperm at fertilization
23. Reliability of aneuploidy estimates in human sperm: Results of fluorescence in situ hybridization studies using two different scoring criteria
24. Analysis of chromosomal abnormalities in human sperm after chemotherapy by karyotyping and fluorescence in situ hybridization (FISH)
25. Chromosomal abnormalities in sperm from testicular cancer patients before and after chemotherapy
26. Analysis of human sperm karyotypes in testicular cancer patients before and after chemotherapy
27. Analysis of sperm chromosome complements before, during, and after chemotherapy
28. Potential genetic risk of using semen collected during chemotherapy
29. Increased aneuploid frequency in spermatozoa from a Hodgkin's disease patient after chemotherapy and radiotherapy
30. Chromosome segregation in mitosis and meiosis
31. Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: Long-term results of a prospective trial
32. Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm
33. Segregation of recombined chromosomes in meiosis I require DNA topoisomerase II
34. Disomic and diploid meiotic products in Saccharomyces cerevisiae, effect of vincristine, vinblastine, adriamycin, bleomycin, mitomycin C and cyclophosphamide
35. The management of stage I testis cancer
36. Mutagenic effects of bleomycin in Drosophila melanogaster
37. Management of stage II seminoma
38. Fluorescence in situ hybridization to Y chromosomes in decondensed human sperm nuclei
39. Analysis of bleomycin-induced chromosomal aberrations in Chinese hamster primary embryonic cells by FISH using arm-specific painting probes